Cabot Corp (CBT) director Christine Yan reports 2,298-share equity grant
Rhea-AI Filing Summary
Cabot Corporation director Christine Y. Yan reported receiving 2,298 shares of Cabot common stock on January 8, 2026, as an acquisition transaction. The shares were credited at a price of $0.00 per share under Cabot's Non-Employee Directors' Deferral Plan, meaning they represent deferred director compensation rather than an open-market purchase. Following this transaction, Yan beneficially owned 17,171 shares of Cabot common stock in direct form. This filing reflects routine equity-based compensation for a non-employee director rather than a cash trade in the stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,298 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Cabot Corp (CBT) report for Christine Y. Yan?
Cabot Corp director Christine Y. Yan reported an acquisition of 2,298 shares of Cabot common stock on January 8, 2026, coded as transaction type "A" (acquired).
Is Christine Y. Yan a director or officer of Cabot Corp (CBT)?
Yes. The Form 4 identifies Christine Y. Yan as a director of Cabot Corp and indicates she is not reported as an officer or 10% owner in this filing.
Does this Cabot Corp (CBT) Form 4 involve derivative securities or only common stock?
The reported transaction involves Cabot common stock as a non-derivative security. The section for derivative securities is present but contains no reported derivative transactions in this excerpt.